NCT05710848 - A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Non-muscle-invasive Bladder Cancer

Interventions

DRUG

STM-416

STM-416 monotherapy

Trial Locations (10)

RECRUITING

Duke Cancer Center, Durham

RECRUITING

Carolina Urologic Research Center, Myrtle Beach

RECRUITING

University of Florida, Gainesville

RECRUITING

Urology Associates, P.C., Nashville

RECRUITING

The Ohio State University, Columbus

RECRUITING

University of Texas Southwestern Medical Center, Dallas

RECRUITING

Baylor College of Medicine, Houston

RECRUITING

Houston Methodist, Houston

RECRUITING

Arizona Urology Specialists, Tucson

RECRUITING

Beth Israel Deaconess Medical Center, Boston